Now showing items 1-6 of 6
Clinical and Radiologic Assessments to Predict Breast Cancer Pathologic Complete Response to Neoadjuvant Chemotherapy
(Kluwer Academic Publishers; Springer, 2005-08)
To prospectively compare the ability of clinical examination, mammography, vascularity-sensitive ultrasound, and magnetic resonance imaging (MRI) to determine pathologic complete response (CR) in breast cancer patients ...
RhoC-GTPase is a Novel Tissue Biomarker Associated with Biologically Aggressive Carcinomas of the Breast
(Kluwer Academic Publishers; Springer, 2005-09)
Background. There is a need for reliable predictors of breast cancer aggressiveness that will further refine the staging classification and help guide the implementation of novel therapies. We have identified RhoC as being ...
Current Issues in the Surgical Management of Breast Cancer: A Review of Abstracts from the 2002 San Antonio Breast Cancer Symposium, the 2003 Society of Surgical Oncology Annual Meeting, and the 2003 American Society of Clinical Oncology Meeting
(Blackwell Science Inc, 2004-01)
Three areas of development in the surgical management of breast cancer received significant attention in 2003—breast-conserving surgery, sentinel lymph node (SLN) biopsy, and ductal lavage. Provocative investigations ...
Does the Method of Biopsy Affect the Incidence of Sentinel Lymph Node Metastases?
(Blackwell Publishing Inc, 2006-01)
More detailed examination of the sentinel lymph node (SLN) in breast cancer has raised concerns about the clinical significance of micrometastases, specifically isolated tumor cells detected only through immunohistochemical ...
Determinants of Breast Conservation Rates: Reasons for Mastectomy at a Comprehensive Cancer Center
(Blackwell Publishing Ltd, 2009-01)
Immunologic response to cryoablation of breast cancer
(Kluwer Academic Publishers; Springer, 2005-03)
Purpose .With improvements in breast imaging and image-guided interventions, there is interest in ablative techniques for breast cancer. Cryosurgery initiates inflammation and leaves tumor-specific antigens intact, which ...